Status:
COMPLETED
Fast Assay for Pathogen Identification and Characterization
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Jessa Hospital
University of Zagreb
Conditions:
Bacteremia
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
Sepsis is a life-threatening disease caused by a dysregulated host response to infection. This can lead to organ-dysfunction and septic shock, which is a subset of sepsis where underlying abnormalitie...
Detailed Description
This study is a follow-up study of the first prospective study performed in 2017 in the same hospital. The ClinicalTrials.gov ID number of the previous study was NCT03025802.
Eligibility Criteria
Inclusion
- Patients for whom blood cultures are drawn
- Age ≥ 18
Exclusion
- Age \< 18
- Patients who are not hospitalized and sent home after ED admission
- Patients from the haematology department
- Duplicate blood cultures from the same bacteraemia episode (blood cultures drawn \<7 days after first blood culture)
Key Trial Info
Start Date :
February 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 17 2020
Estimated Enrollment :
1957 Patients enrolled
Trial Details
Trial ID
NCT03841162
Start Date
February 12 2019
End Date
April 17 2020
Last Update
April 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Hospital
Hasselt, Limburg, Belgium, 3500